In Veritas Medical Diagnostics, Inc.
IVME · OTC
7/31/2021 | 7/31/2007 | 7/31/2006 | 7/31/2005 | |
|---|---|---|---|---|
| Market Cap | $11 | $284 | $7,713 | $14,712 |
| - Cash | $0 | $0 | $61 | $2 |
| + Debt | $0 | $3,668 | $2,828 | $1,704 |
| Enterprise Value | $11 | $3,952 | $10,480 | $16,414 |
| Revenue | $0 | $0 | $1,271 | $880 |
| % Growth | – | -100% | 44.5% | – |
| Gross Profit | $0 | $0 | $1,271 | $875 |
| % Margin | – | – | 100% | 99.5% |
| EBITDA | -$108 | -$2,709 | -$983 | -$2,238 |
| % Margin | – | – | -77.4% | -254.4% |
| Net Income | -$108 | -$3,671 | -$1,849 | -$2,451 |
| % Margin | – | – | -145.4% | -278.5% |
| EPS Diluted | -0.002 | -0.062 | -0.034 | -0.047 |
| % Growth | 97.1% | -84.8% | 27.9% | – |
| Operating Cash Flow | – | -$728 | -$643 | -$741 |
| Capital Expenditures | – | -$69 | -$38 | -$17 |
| Free Cash Flow | – | -$797 | -$681 | -$758 |